Tadalafil: The Evidence for Its Clinical Potential in the Treatment of Pulmonary Arterial Hypertension

Core Evidence - New Zealand
doi 10.2147/ce.s7438
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

Informa UK Limited

Related search

Tadalafil Therapy for Pulmonary Arterial Hypertension

Circulation
Cardiovascular MedicinePhysiologyCardiology
2009English

Oral Tadalafil in Children With Pulmonary Arterial Hypertension

Drug Research
MedicineDrug Discovery
2015English

Selexipag for the Treatment of Pulmonary Arterial Hypertension

Expert Opinion on Pharmacotherapy
MedicinePharmacology
2016English

Selexipag for the Treatment of Pulmonary Arterial Hypertension

Expert Opinion on Pharmacotherapy
MedicinePharmacology
2014English

Updated Evidence-Based Treatment Algorithm in Pulmonary Arterial Hypertension

Advances in Pulmonary Hypertension
2009English

Clinical End-Points and Surrogate Markers of Pulmonary Arterial Hypertension in the Light of Evidence-Based Treatment

Anadolu Kardiyoloji Dergisi/The Anatolian Journal of Cardiology
2010English

Future Perspectives for the Treatment of Pulmonary Arterial Hypertension

Advances in Pulmonary Hypertension
2009English

Telangiectases in Scleroderma: A Potential Clinical Marker of Pulmonary Arterial Hypertension

Journal of Rheumatology
RheumatologyAllergyImmunology
2009English

Ambrisentan for the Treatment of Pulmonary Arterial Hypertension: Improving Outcomes

Patient Preference and Adherence
PharmacologyHealth PolicyMedicineToxicologySocial SciencesPharmaceutics
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy